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How to assess background activity: introducing a
histogram-based analysis as a first step for accurate
one-step PET quantification
Irene A. Burgera,d, Hebert A. Vargasa, Brad J. Beattieb, Debra A. Goldmana,
Junting Zhengc, Steven M. Larsona, John L. Hummb and
Charles R. Schmidtleinb
Many common PET segmentation methods for malignant
lesions use surrounding background activity as a
reference. To date, background has to be measured
by drawing a second volume of interest (VOI) in nearby,
undiseased tissue. This is time consuming as two VOIs
have to be determined for each lesion. The aim of our study
was to analyse whether background activity in different
organs and body regions could be calculated from the
tumour VOI by histogram analyses. The institutional review
board waived informed consent for this retrospective study.
For each of the following tumour types and areas – head
and neck (neck), lung, hepatic metastasis (liver),
melanoma (skin), and cervix (pelvis) – 10 consecutive
patients with biopsy-proven tumours who underwent
18F-fluorodeoxyglucose-PET in January 2012 were
retrospectively selected. One lesion was selected and two
readers drew a cubical VOI around the lesion (VOItumour)
and over the background (VOIBG). The mean value of
VOIBG was compared with the mode of the histogram,
using equivalence testing with an equivalence margin
of ±0.5SUV. Inter-reader agreement was analysed for
the mean background, and the mode of the VOItumour
histogram was assessed using the concordance
correlation coefficient. For both readers, the mode
of VOItumour was equivalent to the mean of VOIBG
(P<0.0001 for R1 and R2). The inter-reader agreement
was almost perfect, with a concordance correlation
coefficient of greater than 0.92 for both the mode of
VOItumour and the mean of VOIBG. Background activity
determined within a tumour VOI using histogram analysis
is equivalent to separately measured mean background
values, with an almost perfect inter-reader agreement.
This could facilitate PET quantification methods based on
background values without increasing workload. Nucl Med
Commun 35:316–324 c 2014 Wolters Kluwer Health |
Lippincott Williams & Wilkins.
Nuclear Medicine Communications 2014, 35:316–324
Keywords: background definition, 18F-fluorodeoxyglucose quantification,
histogram mode, PET segmentation, semiautomatic
Departments of aRadiology, bMedical Physics, cEpidemiology-Biostatistics,
Memorial Sloan-Kettering Cancer Center, New York, New York, USA and
dDepartment of Radiology, University Hospital Zurich, Zurich, Switzerland
Correspondence to Irene A. Burger, MD, Department of Radiology, University
Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
Tel: + 41 44 255 11 11; fax, + 41 44 255 44 14;
e-mail: irene.burger@usz.ch
Received 26 July 2013 Revised 3 October 2013 Accepted 21 October 2013
Introduction
The ability of 18F-fluorodeoxyglucose (18F-FDG) PET/
computed tomography (CT) to provide a quantitative
estimation of tumour burden has played an important role
in its success in therapy response assessment [1].
Currently, the most commonly used quantification method
in routine clinical practice is the maximum standardized
uptake value (SUVmax), normalized either to weight, lean
body mass or body surface [2]. Although there are several
advantages in the use of SUVmax, including ease of
measurement and good interobserver reproducibility, there
are also major limitations, such as the high statistical noise
that derives from a single voxel analysis [3–5]. In addition,
SUV measurements do not take into account the amount of
physiologic background (BG) activity, which varies between
different anatomical sites and different patients, thus
making it impossible to use absolute SUV cutoff values to
separate normal physiological activity from malignant or
inflammatory activity.
To estimate the PET volume, an SUVmax-based threshold
method (42% of the SUVmax) was introduced [6].
Because of the heterogeneous nature of tumours and
the surrounding tissues, however, this method was found
to be inaccurate in several studies [7–9]. Multiple
methods have been proposed to deal with the limitation
of 18F-FDG PET volume determination. Central to
most of these approaches is defining the average BG
activity around the lesion on PET images. Nestle et al. [9]
proposed a BG-based correction, subtracting the mean
BG and 15% from the peak activity (70% of the hottest
voxels) for spill-over correction, and found that this
approach significantly improved the accuracy of measured
tumour volumes in PETscans. Daisne et al. [10] suggested
an automated lesion-to-BG ratio-adapted threshold to
integrate BG activity into tumour segmentation methods,
which has been shown to yield a higher accuracy compared
with multiple simple threshold-based volume segmenta-
tion tools [11,12].
Technical note
0143-3636 c 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins DOI: 10.1097/MNM.0000000000000045
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Although the need to account for BG activity when
quantifying tracer uptake is generally accepted [1], there
is no agreement on how this should be measured. Some
authors propose using a volume of interest (VOI) placed
over the region adjacent to the tumour with the highest
activity [9,13], whereas others prefer the use of a
population-based BG value for different areas (e.g. soft
tissue and bone) [14]. Both of these approaches are
acceptable; however, the former is time consuming and
observer dependent, particularly in a clinical setting with
multiple lesions per patient, whereas the latter may not
be applicable to organs that are known to have wide
variability in BG activity among different patients, such as
the liver. Drever and colleagues [15,16] used a histogram-
based analysis to determine BG activity in phantom
studies to determine a local contrast-based approach for
threshold segmentation of PET volumes. If this principle
was robust enough to yield reliable values for BG activity
in the much more heterogeneous and tumour and BG
setting of real patients, this could be a valuable
alternative to manually drawn adjacent VOIs or popula-
tion-based BG values. To our knowledge this has never
been followed up with patient data.
Thus, the purpose of this study was to automatically
derive the BG activity from the tumour VOI, using simple
histogram analysis, and to test the robustness of the
method for different reconstruction algorithms in phantoms
and within different organs with variable tumour-to-BG
ratios in patients.
Materials and methods
Phantom analysis
To test for the robustness of the histogram-based BG
measurement under different image reconstruction methods
affecting image resolution or noise, we selected a phantom
with a homogeneous BG: a standard American College of
Radiology (ACR; flangeless Esser PET Phantom; Data
Spectrum Corporation, Durham, North Carolina, USA)
cylindrical phantom with separately fillable cylinders, used
for scanner quality assurance testing (Fig. 1a). The scan was
performed in accordance with the ACR guidelines, assuming
a 70kg patient with a 444MBq injection as the reference
(36MBq for the BG and 16MBq diluted in 1000 cm3 for the
hot cylinder volumes). After filling the BG volume (6.3 l),
the phantom had a homogeneous BG with a mean SUV of 1.
After 60min, the phantom was scanned for 3min. The data
were reconstructed at 10, 15, 20, 30, 45, 60, 90 and 180 s,
resulting in a continuous decrease in noise and increase in
contrast resolution. In addition the 3-min scan was
reconstructed using one, two, three or four iterations each
using 20 subsets and two different matrix sizes of 128 and
256 with 6.3mm postreconstruction smoothing and three-
point [121] z-axis smoothing. A VOIlesion was placed over the
largest cylinder. The mode of the histogram was defined as
the most common voxel value in the VOIlesion and was
compared with the mean VOIBG (Fig. 2).
To assess the influence of an increase in VOI size on the
mode of the histogram, a phantom with a heterogeneous
BG was selected. The Society of Nuclear Medicine
Clinical Trials Network (SNM-CTN) anthropomorphic
thorax phantom (Chest Oncology Phantom) was filled in
accordance with the SNM-CTN instructions and recon-
structed using our clinical settings: ordered subset
expectation maximization (OSEM) with two iterations
over 20 subsets, 6.3-mm postreconstruction transaxial
filtering and three-point [121] smoothing along the z-axis
(Fig. 1b). A cubical VOI was placed around a spherical
lesion, abutting the edges of the lesion with an edge
length of 30mm. Thereafter, the diameter of the
VOIlesion was continuously enlarged over four steps,
yielding five VOIlesions with an increasing size. The mode
of each histogram for the VOIlesions was determined. As a
reference, the mean SUV in a fixed-size cubical VOIBG
was used (Fig. 3).
Patient selection
The Institutional Review Board waived the informed
consent requirement for this retrospective study. Patients
who underwent 18F-FDG PET/CT at our institution for
routine clinical purposes between January 2012 and
March 2012 were screened. To address a large variety of
tumour-to-BG ratios, we included 50 patients, 10
consecutive patients with known malignancies in five
different areas: head and neck squamous cell carcinoma
(neck), non-small-cell lung cancer (lung), hepatic me-
tastasis of colon cancer (liver), cutaneous melanoma
(skin) and uterine cervical cancer (pelvis).
Image acquisition
All patients underwent PET/CT on a Discovery STE or
Discovery 600/690 system (GE Medical Systems,
Waukesha, Wisconsin, USA); 60min after the injection
of 400–500MBq (nominally 444MBq) of 18F-FDG, a low-
dose attenuation-correction CT scan (120–140 kV,
B80mA with patient-specific variations) was acquired.
This was followed by acquisition of PETemission images
from the pelvis to the skull. Attenuation correction was
routinely applied and images were reconstructed using
iterative algorithms (GE DSTE – OSEM with two
iterations over 20 subsets and 6.3mm postreconstruction
axial filtering and three-point [121] smoothing along
the z-axis and GE D690 ToF/PSF OSEM with two
iterations over 16 subsets and 6.0mm postreconstruction
transaxial filtering and three-point [121] smoothing along
the z-axis). Before the examination, patients were asked
to fast for at least 6 h, but liberal intake of water was
allowed.
Image analysis
One lesion per patient was identified for analysis. Two
readers (R1/R2) independently placed cubical VOIs
around each lesion (VOItumour). First, a large VOItumour
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Fig. 1
(a) To test the robustness of the histogram-based background calculation under different image reconstruction settings, a standard American
College of Radiology (ACR) cylindrical phantom (flangeless Esser PET Phantom) was used. (b) To assess the influence of the volume of interest
(VOI) size on the background estimation, a Society of Nuclear Medicine Clinical Trials Network (SNM-CTN) anthropomorphic thorax phantom was
used. (c) Axial image of the cylindrical phantom, which was filled and scanned according the ACR guidelines. (d) Coronal maximum-intensity
projection image of the thorax phantom, which was filled in accordance with the SNM-CTN instructions and reconstructed using our clinical settings.
One lesion was selected in both phantoms for further analysis (red arrow).
Fig. 2
(a) Axial CT image of the ACR cylindrical phantom with the VOI around the selected cylinder. (b–e) Four examples of axial 18F-FDG PET images of
the same slice after different image reconstructions: (b) with a 10-s acquisition time, (c) with a 3-min acquisition time, (d) with four iterations and 20
subsets each with a matrix size of 128 and (e) with only one iteration and 20 subsets and a matrix of 256. ACR, American College of Radiology;
CT, computed tomography; 18F-FDG, 18F-fluorodeoxyglucose; VOI, volume of interest.
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Fig. 3
R L R
P P
HA
L
(a) (b)
+ +
18F-fluorodeoxyglucose (a) axial and (b) coronal PET images of the anthropomorphic thorax phantom with simulated lung lesions, illustrating the
different volume of interest (VOI) sizes placed around the selected lesions, with a 30mm (dark blue) to 50mm (orange) edge length. A background
VOI (VOIBG, red) was placed adjacent, with an edge length of 30mm. The mean standardized uptake value (SUV) in the VOIBG is 0.49SUV.
The mode of the VOIlesion, defined as the most common voxel value in the VOIlesion, ranged from 0.50–0.54SUV.
Fig. 4
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18F-FDG PET images of hepatic metastasis of colon cancer (patient 7) with the inserted volumes of interests (VOIs) by reader 1 in (a) axial,
(b) sagittal and (c) coronal planes. (d) An additional axial fused 18F-FDG PET/CT image with three VOIs: a large VOI (VOIL; blue), a small VOI
(VOIS; green, which is just abutting the tumour margins) and the separate VOIBG (red) over healthy tissue. CT, computed tomography;
BG, background; 18F-FDG, 18F-fluorodeoxyglucose.
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(VOIL) was drawn generously around the lesion with the
margins of the VOI placed more than 1 cm away from the
edge of the lesion. Thereafter, a small VOItumour (VOIS)
was drawn tightly around the lesion with the margin of
the VOI abutting the edge of the lesion. For each patient,
a third VOI was placed in a region away from the lesion
but within the same organ to determine the mean BG
(VOIBG) (Fig. 4). For each VOI, care was taken not to
include increased 18F-FDG activity from adjacent struc-
tures (e.g. excreted tracer in the bladder/ureter).
Fig. 5
125
100
75
50
N
um
be
r o
f v
ox
el
s
25
0
1 2 3
SUV
4
Mode VOlL = 1.768
VOlL
VOlBG
VOlS
Mode VOlS = 1.811
Mode VOlBG = 1.674
5
The three rebinned and scaled histograms derived from the large (blue) and the small (green) tumour volumes of interest (VOItumour), as well as the
background VOI (VOIBG; red) of the same lesion as in Fig. 1, with the VOIs illustrated on a transverse
18F-FDG PET plane in the right upper corner.
The mean background value (1.676SUV) is nearly identical to the mode of the histogram in VOIBG (1.674SUV) and is very close to the mode of the
histogram values in both the large (1.768SUV) and the small (1.811SUV) VOItumour.
18F-FDG, 18F-fluorodeoxyglucose; VOI, volume of interest;
SUV, standardized uptake value.
Table 1 Phantom study results
ACR phantom – acquisition time (s) Mode VOIlesion (SUV) Mean VOIBG (SUV)
10 0.81 0.93
15 0.86 0.95
20 0.99 0.93
30 0.96 1.04
45 0.99 1.02
60 0.98 1.02
90 0.95 1.02
180 1.03 1.01
ACR phantom – reconstruction: iteration subsets (matrix) Mode VOIlesion (SUV) Mean VOIBG (SUV)
120 (128) 1.03 1.01
220 (128) 1.10 1.01
320 (128) 1.07 1.01
420 (128) 1.06 1.01
120 (256) 1.06 1.01
220 (256) 1.01 1.01
320 (256) 1.01 1.01
420 (256) 0.99 1.02
Thorax phantom – increasing VOI edge length (mm) Mode VOIlesion (SUV) Mean VOIBG (SUV)
30 0.51 0.49
34 0.54 0.49
38 0.50 0.49
42 0.50 0.49
50 0.50 0.49
ACR, American College of Radiology; SUV, standard uptake value; VOIBG, background volume of interest; VOIlesion, lesion volume of interest.
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Table 2 Difference between the mean VOIBG and the mode of the histograms of VOIL and VOIS
Reader 1 Reader 2
MH VOIL –mean VOIBG MH VOIS –mean VOIBG MH VOIL –mean VOIBG MH VOIS –mean VOIB
Mean 0.0007 0.1778 –0.0011 0.1877
SD 0.3025 0.4231 0.334 0.3982
Range –1.0022 to 0.8438 –0.9913 to 1.3254 –0.7341 to 1.1881 –0.7053 to 1.5014
Two-sided 95% CI of the mean – 0.0831 to 0.0846 –0.0605 to 0.2951 –0.0937 to 0.0915 –0.0774 to 0.2981
Equivalence conclusion Yes Yes Yes Yes
CI, confidence interval; MH, mode of the histogram; VOIBG, background volume of interest; VOIL, large volume of interest; VOIS, small volume of interest.
Fig. 6
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Hepatic metastasis of colon cancer
Non-small-cell lung cancer
Overview of all patients (1–10) for each tumour type: the mode of the histogram (MH), defined as the most common voxel value within a volume of
interest (VOI), given for both readers (reader 1, blue; reader 2, green) and both the large VOI (VOIL, square) and the small VOI (VOIS, star) compared
with the mean VOIBG (diamonds, red). The most significant equivalence is reached in areas with homogeneous BG (lung, skin or liver). For lesions in
the small pelvis (cervical cancer) the variability is higher, but this is also true for separately drawn dedicated VOIBG. BG, background;
SCC, squamous cell carcinoma; SUV, standardized uptake value.
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In accordance with that in the study by Nestle et al. [9]
for lesions surrounded by tissues with different 18F-FDG
activities (e.g. lung and liver/soft tissue and air), the
structure with a visually higher 18F-FDG uptake was
defined as a ‘relevant BG’.
The geometrical basis of VOI analysis with a most
commonly round lesion captured within a square VOI
leads to a ratio of BG-to-tumour voxels of nearly 1 or
more. Therefore, the more homogeneous BG is repre-
sented by the mode of the histogram. The mode values
for the histograms VOIS and VOIL were compared with
the mean VOIBG value.
Histograms representing the number of voxels (x-axis) for
every SUV (y-axis) within a selected VOI were built
for VOIlesion, as well as VOIL and VOIs of both readers, for
the phantom studies and exported using dedicated software
(Pmod 3.3; Pmod Technologies, Zurich, Switzerland).
The software automatically subdivided the SUVs within
the VOI into 256 equal-sized bins. First, all voxels with an
SUV below 0.1 were truncated from the histograms
to remove the extra corporeal parts of the VOI. To
calculate the mode of the histogram the values were
rebinned by an empirical factor of 1/6 to find an
acceptable tradeoff between resolution and noise in the
BG area. The mode was determined from the resulting
histogram (Fig. 5).
Statistical analysis
An equivalence test with an equivalence margin of
0.5 SUV was used to compare the mean value of VOIBG
with the mode of the histogram of VOIS and VOIL for
each reader separately. Concordance correlation coeffi-
cient (CCC) was used to assess interobserver agreement
between mode of the histogram of VOIS and VOIL and
the mean values of VOIBG for readers one and two
(R1, R2). Statistical analyses were carried out on SAS 9.2
(SAS Institute Inc., Cary, North Carolina, USA).
Results
Phantom data
The expected BG value of an SUVmean of 1 for the ACR
phantom was found to be highly reproducible, regardless
of image noise, chosen reconstruction parameters or
matrix size (Table 1). In addition, the gradual increase in
the size of VOIlesion from 30 to 50mm edge length did not
change the mode of the histogram (SUV 0.5–0.54) in the
thorax phantom study, which was nearly identical to the
mean of the VOIBG (SUVmean 0.49) (Table 1).
Patient data
For both readers, the mode of the histogram of both VOIL
and VOIS was equivalent to the mean BG over all tumour
groups (Table 2, Fig. 6).
The inter-reader agreement was very high, with a CCC of
0.920 (95% confidence interval: 0.877–0.963) for the
mean BG, and 0.943 and 0.932, respectively, for the mode
of the histogram of VOIL and VOIS (Table 3).
Discussion
Our study demonstrates that the mean BG activity can be
accurately estimated using a single cubical VOI placed
around a tumour. It also confirms the applicability of the
geometrical principle stating that for a round or roundish
tumour captured within a square VOItumour of the same
size, the ratio of BG-to-tumour voxels is nearly 1 : 1
(Fig. 7). Therefore, the more homogeneous BG was well
represented by the mode of the histogram of the
VOItumour for all tumour types and both VOI sizes.
Histogram analysis for BG definition has been proposed
in phantom studies by assuming that the second peak in
the histogram corresponds to the mean BG activity, as a
large portion of the VOI contained air [15,16]. However,
to our knowledge, this has never been investigated using
real patient data.
Commonly, BG activity for 18F-FDG quantification is
determined by placing a dedicated VOIBG away from the
tumour in adjacent tissue. It has been observed that BG
values are stable within different VOIBG, as
18F-FDG
activity is rather homogeneous within normal organs [9].
However, our results show that the inter-reader variability
of VOIBG values is comparable with that in the analysis of
BG activity with the mode of the histogram. An atlas-
based method to correct for BG activity was proposed for
the quantitative assessment of prostate cancer metastasis
by measuring SUVmax in the iliac crest and gluteal muscle
in 65 scans, subtracting the mean SUVmax of bone in
osseous lesions and the mean SUVmax value of the gluteal
muscle for lymph node metastasis [14]. This is reason-
able in tissue with small variability in 18F-FDG activity
among different patients; however, for lesions in the liver
or pelvis, it does not seem to be feasible.
Clinical guidelines gaining more and more acceptance
suggest the use of BG-based methods for PET volume
measurement [1]. This has been implemented for
BG-activity-based methods using a dedicated VOIBG for
each lesion to determine PET volume and has been shown
to be more accurate than a threshold-based analysis [11].
With the presented method, BG values could now be
automatically integrated into clinical lesion analysis.
Table 3 Concordance correlation coefficient
CCC 95% CI
MH VOIL 0.943 0.912, 0.974
MH VOIS 0.932 0.895, 0.969
Mean VOIBG 0.920 0.877, 0.963
CCC, concordance correlation coefficient; CI, confidence interval; MH, mode of
the histogram; VOIBG, background volume of interest; VOIL, large volume
of interest; VOIS, small volume of interest.
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The technique is highly reproducible, as shown by the high
degree of agreement among patients, with a CCC of greater
than 0.9 for all measurements between two independent
readers, as well as by the phantom data that gave stable
results for a wide variety of reconstruction methods, signal-
to-noise ratios and VOI sizes. When drawing a VOItumour for
BG analysis in a patient, especially if the tumour is
surrounded by two different tissues, one consideration has
to be followed: the most active part must be regarded as
the relevant BG and needs to be dominant in the
VOItumour. Therefore, more voxels of the VOI have to be
in the area with higher BG activity. This simple considera-
tion could be followed by both observers and might have
contributed to the high CCC, even in more challenging
areas such as the liver dome (liver/lung interface) or
cutaneous lesions (soft tissue/air interface).
In clinical routine, a dedicated VOIBG would likely increase
the workload and would also have to be integrated into the
clinical workstation to link the VOIBG with the correspond-
ing VOItumour for each lesion. This is especially important
for patients with extensive disease and would likely
increase the evaluation time and effort. One of the
strengths of our proposed histogram-based BG analysis is
that it can be integrated with modest programming effort
as an automated feature in existing vendor software,
facilitating more quantitative PET analysis and tumour
segmentation without increasing clinical work.
The present study is only the first step in a potential
histogram-based PET quantification. It was carried out to
show that the BG can be determined irrespective of the
organ site or reconstruction algorithm. Further limitations
were the small sample sizes per tumour entity. However,
our goal was to find a method to reliably measure BG
activity throughout the body. Therefore, an analysis of a
variety of different organ systems with validation of the
overall equivalence was chosen. In addition, when binning
the derived data for histogram analysis we chose an
empirical factor based on visual interhistogram comparison
to achieve an acceptable tradeoff between resolution and
noise in the BG area. We are aware that other methods exist
for doing this and that the factor used will depend on the
presetting, which varies for different software solu-
tions [17–19]. Finally, the method that we used to analyse
BG activity requires a dedicated software that, although
relatively simple, is not currently available in standard
clinical viewing software packages. Modification of the
existing vendor software would be necessary to facilitate
this approach for more quantitative PET analysis.
Conclusion
A simple histogram analysis of the tumour VOI can enable
automatic and accurate determination of the mean BG
activity on PET images. This could lead to a more
accurate PET quantification method to assess the total
tumour activity, without any increase in workload.
Fig. 7
BG1 with: a = 2r
Volumes: sphere =    πr3 (r = radius); cube = a3 (a = edge length)
BG2 with: a = 3r
BG1
Tu
(b)
(a)
BG2
Tu
=
= =
= = 0.92
= 5.45
πr3
6 − π
81 − 4π
4π
π
(2r)3 −
4
3(    πr
3)
4
3
πr3
(3r)3 −
4
3(    πr
3)
4
3
4
3
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